Tag: ataxia market forecast

  • Global Ataxia Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Global Ataxia Market Analysis: Size, Drivers, Trends, Opportunities, And Strategies

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    At What Rate is the Ataxia Market Predicted to Expand Between 2024 and 2033?

    Recent years have seen an upward trajectory in the size of the ataxia market. The market is predicted to escalate from $33.78 billion in 2023 to $37.01 billion in 2024, reflecting a compound annual growth rate (CAGR) of 9.6%. Factors contributing to this growth during the historical period include the rarity of treatment choices, forward strides in neurological studies, heightened understanding of rare diseases, advancements in diagnosis technologies, and an amplified concentration on genetic elements.

    The market size of ataxia is projected to experience significant expansion in the coming years, with an anticipated surge to $51.3 billion in 2028, representing a compound annual growth rate (CAGR) of 8.5%. Factors like expedited development of ataxia drugs, increased investment in rare disease studies, adoption of precision medicine techniques, emphasis on patient advocacy and an enhanced understanding of the genetic aspects of ataxia are responsible for this projected growth in the forecast period. The future trends in the forecast period include incorporation of digital health tools in managing ataxia, progressing with gene therapies for ataxia treatments, increasing collaborative efforts in research, focus on patient-centric care schemes, and utilization of telemedicine for ataxia consultations.

    Claim Your Free Sample of the Global Ataxia Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12218&type=smp

    What Forces Are Boosting the ataxia Market’s Growth?

    The increased intake of alcoholic beverages is projected to stimulate expansion in the ataxia market. Drinking beverages containing ethanol, typically consumed orally, is what’s meant by alcohol consumption. Chronic misuse of alcohol results in a common form of toxic ataxia known as cerebellar degeneration. Individuals with alcohol addiction often exhibit symptoms like lower limb tremors in standing position and unsteady walking. The Global Beer Consumption Report for 2021, provided by Japan’s comprehensive beverage firm, Kirin Holdings Company Limited, in December 2022, stated that approximately 185.60 million kiloliters of beer were drank across the globe in 2021, indicating a 4.0% growth compared to the preceding year. As the pandemic’s effects began to ease, global beer consumption in 2021 surged by around 7.13 million kiloliters (equal to around 11.3 billion 633-ml bottles) from 2020, totalling about 185.6 million kiloliters (an increment of 4.0% from the previous year, or around 293.2 billion 633-ml bottles). Consequently, the escalation in alcohol intake is fueling the ataxia market’s growth.

    What Key Segments Make Up the Ataxia Market?

    1) By Type: Friedreich’s Ataxia, Ataxia-telangiectasia, Episodic Ataxia, Other Types

    2) By Product: Treatment, Diagnosis

    3) By Dosage Form: Solid, Liquids, Other Dosage Forms

    4) By Route of Administration: Oral, Parenteral, Other Routes of Administration

    5) By End User: Hospital, Clinics, Home Healthcare, Other End-Users

    What Are the Latest Trends Impacting the Ataxia Market?

    In the realm of the ataxia market, one of the principal trends catching the limelight is product innovation. Numerous significant businesses that are operative in the ataxia market are centred around the origination of novel drugs and products to maintain their stronghold. For instance, Reata Pharmaceuticals, an enterprise rooted in biotechnology from the U.S, publicised that in February 2023, the US Food and Drug Administration (FDA) approved their new product, SKYCLARYS (omavaloxolone). This product stands as the only medication approved for treating patients suffering from Friedreich’s ataxia, including adults and adolescents over 16. On administering this oral medication once daily by the 48th week, there was a marked statistical decrease in mFARS (modified Friedreich’s Ataxia Rating Scale) scores, indicating lessened impairment compared to a placebo. Commonly, the diagnosis of this highly rare, genetically inherited neurological disorder, Friedreich’s ataxia, is identified typically around adolescence.

    Order Now for Fast Delivery of Your Ataxia Market Report!

    https://www.thebusinessresearchcompany.com/report/ataxia-global-market-report

    What Regions Are Dominating the Ataxia Market Growth?

    North America was the largest region in the ataxia market in 2023. Asia-Pacific is expected to be the fastest-growing region in the ataxia market report during the forecast period. The regions covered in the ataxia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Ataxia Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the ataxia market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Ataxia Market Include

    1. Ataxia Market Executive Summary

    2. Ataxia Market Segments

    3. Ataxia Market Size And Template Market Growth Rate

    4. Key Ataxia Market Trends

    5. Major Ataxia Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Ataxia Market

    26. Top Ataxia Companies

    27. Ataxia Market Opportunities And Strategies

    28. Ataxia Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 5 Key Insights On The Ataxia Market 2024

    5 Key Insights On The Ataxia Market 2024

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Ataxia Global Market Report 2024, the ataxia market is expected to show significant growth in the forecast period.

    1. Introduction
    • Robust growth observed in the ataxia market.
    • Expected rise from $33.78 billion in 2023 to $37.01 billion in 2024 at a CAGR of 9.6%.
    1. Driving Forces
    • Limited treatment options drive research and development.
    • Advances in neurological research contribute to treatment innovation.
    • Growing awareness of rare diseases enhances diagnosis and treatment.
    • Evolution of diagnostic technologies aids in early detection.
    • Increased focus on genetic factors elucidates disease mechanisms.
    1. Projected Growth and Trends
    • Anticipated growth to $51.3 billion in 2028 at a CAGR of 8.5%.
    • Accelerated drug development for ataxia treatment.
    • Rising investments in rare disease research propel market expansion.
    • Adoption of precision medicine approaches enhances treatment efficacy.
    • Emphasis on patient advocacy and understanding genetic basis of ataxia.

    View More On The Ataxia Market Report 2024 – https://www.thebusinessresearchcompany.com/report/ataxia-global-market-report

    1. Impact of Alcohol Consumption on Ataxia
    • Surge in alcohol consumption fuels market growth.
    • Chronic alcohol misuse contributes to cerebellar degeneration, a form of acquired toxic ataxia.
    • Alcoholism linked to lower limb postural tremors and gait ataxia.
    • Global Beer Consumption Report highlights a significant increase in beer consumption worldwide.
    • Rise in alcohol consumption drives demand for ataxia treatments.
    1. Key Players in the Market
    • Pfizer Inc.
    • Johnson & Johnson Services Inc.
    • F. Hoffmann-La Roche Ltd.
    • AbbVie Inc.
    • Bayer AG
    • And more.
    1. Product Innovations
    • Focus on groundbreaking drug developments targeting ataxia.
    • Reata Pharmaceuticals obtains FDA approval for SKYCLARYS, the first drug for Friedreich’s ataxia.
    • Solid Biosciences Inc. acquires AavantiBio Inc., expanding its portfolio of neuromuscular and cardiac programs.
    • Emphasis on innovation to address unmet medical needs in ataxia treatment.
    1. Market Segmentation
    • Types: Friedreich’s ataxia, ataxia-telangiectasia, episodic ataxia, and others.
    • Products: Treatment and diagnosis.
    • Dosage forms: Solid, liquids, and others.
    • Routes of administration: Oral, parenteral, and others.
    • End-users: Hospitals, clinics, home healthcare, and others.
    1. Regional Dynamics
    • North America leads the ataxia market in 2023.
    • Asia-Pacific emerges as the fastest-growing region during the forecast period.

    In summary, the ataxia market experiences significant growth driven by various factors including research advancements, increased awareness, and product innovations. The rise in alcohol consumption underscores the urgency in addressing ataxia-related disorders. With continued investment in research and development, coupled with strategic partnerships and acquisitions, the market is poised for sustained expansion. Embracing digital health solutions and patient-centric care models will further enhance treatment outcomes, offering hope to individuals affected by ataxia worldwide.

    Request A Sample Of The Global Ataxia Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12218&type=smp